Background: Mitomycin C (MMC) is used to prevent corneal opacity after photorefractive
keratectomy (PRK). This study sought to determine the effect of MMC on tear film function …

PURPOSE: To assess the effects of adjuvant mitomycin C (MMC) on tear function tests after
photorefractive keratectomy (PRK) for myopia. METHODS: In this prospective, randomized …

Photorefractive keratectomy (PRK) is considered a safe approach laser procedure with a
clinical significance in correcting myopia results. PRK requires removing the whole …

PURPOSE: To evaluate the safety and efficacy of 5 seconds of mitomycin-C (MMC)
application during photorefractive keratectomy (PRK) for low myopia. SETTING: Basir Eye …

Photorefractive keratectomy (PRK) is a safe and effective surgical keratorefractive technique
which is done with the application of mitomycin-C (MMC) in cases of high myopia to prevent …

Purpose: To evaluate the long-term outcomes of two-step versus single application of
mitomycin-C (MMC) during photorefractive keratectomy (PRK) for high myopia. Methods …

PURPOSE: To evaluate the role of topical mitomycin C in corneal wound healing (CWH)
after photorefractive keratectomy (PRK) in highly myopic eyes. DESIGN: Prospective, double …

Purpose To compare the variance in manifest refraction spherical equivalent (MRSE) after
photorefractive keratectomy (PRK) with mitomycin-C (MMC), PRK without MMC, and laser in …

PURPOSE: The aim of the study was to assess the effect of mitomycin-C (MMC) 0.02%
application on corneal endothelium in patients undergoing photorefractive keratectomy …

AIM To study the effect of mitomycin C (MMC) applied during transepithelial photorefractive
keratectomy (TPRK) on the corneal endothelium one week (W1) and three months (M3) after …